Results 1 to 10 of about 480 (153)

Direitos humanos, propriedade privada e educação [PDF]

Trans/Form/Acao, 1985
O presente texto constitui síntese de comunicação do autor à III Conferência Brasileira de Educação (Niterói, outubro de 1984). Afirma-se a necessidade de discutir as raízes da idéia de direitos do indivíduo e seu vínculo, no pensamento fundador de Locke,
Reginaldo Carmello Corrêa de Moraes
exaly   +4 more sources

Historicidade da propriedade privada capitalista e os cercamentos

História: Debates E Tendências, 2018
O objetivo desse artigo é diferenciar os diversos tipos de “propriedade privada”que surgiram em nossa história, desde a Idade Antiga, passando pela Idade Média, até chegar a atual propriedade privada capitalista.
Diogo de Calasans Melo Andrade
exaly   +5 more sources

Validation of the Equine Urticaria Activity Score for the assessment of chronic recurrent urticaria in horses. [PDF]

Vet Dermatol
Background – Recurrent urticaria is common in horses. The pathophysiology is poorly understood and treatment options are limited. Often only glucocorticoids are effective for controlling clinical signs, albeit with potential adverse effects. Studies investigating new treatments need a validated objective scoring system for the grading of skin lesions ...
Birkmann K, Waldern N, Jucker S, Balaschitsch K, Zablotski Y, Fettelschoss-Gabriel A.   +5 more
europepmc   +2 more sources

The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis. [PDF]

Vet Dermatol, 2022
Background– Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions. Objectives – To determine if CBD/CBDA is an effective therapy for canine atopic dermatitis (cAD). Conclusions and clinical relevance – Cannabidiol/CBDA as an adjunct therapy decreased pruritus, and not skin ...
Loewinger M, Wakshlag JJ, Bowden D, Peters-Kennedy J, Rosenberg A.   +4 more
europepmc   +2 more sources

Clinical efficacy of spray-based heat-treated lactobacilli in canine atopic dermatitis: a preliminary, open-label, uncontrolled study. [PDF]

Vet Dermatol, 2021
Background – Canine atopic dermatitis (cAD) is a common inflammatory and pruritic skin disease, with various treatment options. The use of topical products containing natural ingredients has proven increasingly popular. Objective – To evaluate the effects of a spray solution containing heat‐killed Lactobacillus rhamnosus and L. reuteri, on the clinical
Santoro D, Fagman L, Zhang Y, Fahong Y.
europepmc   +2 more sources

A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine-month controlled study. [PDF]

Vet Dermatol, 2022
Background – Canine atopic dermatitis (cAD) is a common chronic relapsing pruritic skin disease for which management commonly relies on life‐long use of immunomodulatory drugs. A number of the medications used are associated with adverse effects and the potential for complications during long‐term use.
Watson A, Rostaher A, Fischer NM, Favrot C.   +3 more
europepmc   +2 more sources

Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration. [PDF]

Vet Dermatol
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Villalobos WR, Ferreira T, Borek F, Santoro D, Ferrer L, Farias M.   +5 more
europepmc   +2 more sources

Effect of a ceruminolytic ear cleaner on clinical, microbiological and ear canal microbiome evolution in canine erythemato-ceruminous otitis externa associated with proliferation of Malassezia yeasts. [PDF]

Vet Dermatol
Background – Erythemato‐ceruminous otitis externa (ECOE) is commonly associated with Malassezia spp. and microbial imbalance. Hypothesis/Objective – To assess the clinical performance of an ear cleaner in dogs suffering from ECOE associated with Malassezia spp. overgrowth and to measure its impact on the microbiota. Conclusions and Clinical Relevance –
Briand A, Bensignor E, Dropsy H, Crosaz O, Humeau L, Cheval J, Demontant V, Debi MN, Fantini O, Dal H, Guillot J, Faivre NC.   +11 more
europepmc   +2 more sources

Immunotherapy using pullulan-conjugated Der f 2 allergen in canine atopic dermatitis: An anti-inflammatory agent-sparing approach. [PDF]

Vet Dermatol
Background – Allergen immunotherapy is used as aetiological treatment for canine atopic dermatitis (cAD). Objective – To assess the anti‐inflammatory agent‐sparing effect over 1 year of immunotherapy using pullulan‐conjugated recombinant Der f 2 (rDf2‐P). Conclusions and Clinical Relevance – Der f 2‐P immunotherapy can lead to a rapid reduction in anti‐
Nagata M, Kozakai J, Yoshida A, Kameyama K, Oboso H, Muto H, Ogino S, Tsukui T.   +7 more
europepmc   +2 more sources

A prospective study evaluating the correlation between local weather conditions, pollen counts and pruritus of dogs with atopic dermatitis. [PDF]

Vet Dermatol
Abstract Background Canine atopic dermatitis (cAD) is a hereditary, generally pruritic and predominantly T‐cell‐driven inflammatory skin disease, involving an interplay between skin barrier abnormalities, allergen sensitisation and microbial dysbiosis.
Widorn L, Zabolotski Y, Mueller RS.
europepmc   +2 more sources